Predicting prognosis in prostate carcinoma remains a challenge when using clinical and
pathologic criteria only. We used an array-based DASL® assay to identify molecular …

High Gleason score is currently the best prognostic indicator for poor prognosis in prostate
cancer. However, a significant number of patients with low Gleason scores develop …

Purpose Clinicopathologic features and biochemical recurrence are sensitive, but not
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …

Background: The early detection of prostate cancer has resulted in an increase in the
number of patients with localized prostate cancer and has paralleled the reported reduction …

Prostate cancer (PCa) is a leading cause of cancer-related mortality worldwide. Gleason
score (GS) is one of the best predictors of PCa aggressiveness, but additional tumor …

One of the major problems in management of prostate cancer is the lack of reliable genetic
markers predicting the clinical course of the disease. We analyzed expression profiles of …

The accurate determination of the risk of cancer recurrence is an important unmet need in
the management of prostate cancer. Patients and physicians must weigh the benefits of …

BACKGROUND Gene expression profiling of prostate carcinoma offers an alternative means
to distinguish aggressive tumor biology and may improve the accuracy of outcome …

We report here numerous novel genes and multiple new signatures which robustly predict
prostate cancer (PC) recurrence. We extracted 696 differentially expressed genes relative to …

Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …